Analysis of Circulating Tumor DNA to Predict Risk of Recurrence in Patients With Esophageal and Gastric Cancers

PURPOSE: Circulating tumor DNA (ctDNA) analyses allow for postoperative risk stratification in patients with curatively treated colon and breast cancers. Use of ctDNA in esophagogastric cancers (EGC) is less characterized and could identify high-risk patients who have been treated with curative inte...

Descripción completa

Detalles Bibliográficos
Autores principales: Huffman, Brandon M., Aushev, Vasily N., Budde, Griffin L., Chao, Joseph, Dayyani, Farshid, Hanna, Diana, Botta, Gregory P., Catenacci, Daniel V.T., Maron, Steven B., Krinshpun, Shifra, Sharma, Shruti, George, Giby V., Malhotra, Meenakshi, Jurdi, Adham, Moshkevich, Solomon, Aleshin, Alexey, Kasi, Pashtoon M., Klempner, Samuel J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2022
Materias:
Original Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10530958/
https://www.ncbi.nlm.nih.gov/pubmed/36480779
http://dx.doi.org/10.1200/PO.22.00420

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10530958/
https://www.ncbi.nlm.nih.gov/pubmed/36480779
http://dx.doi.org/10.1200/PO.22.00420

Ejemplares similares